About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT01908179

Markers of Prognosis and Response to Therapy in Patients With Metastatic Brain Tumors Undergoing Stereotactic Radiosurgery (SRS)

This registry study will evaluate patients with metastatic brain tumors undergoing, or having undergone, stereotactic radiosurgery (SRS) at Swedish Medical Center. Clinical outcomes will be evaluated ...

Lead sponsor: Swedish Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Tracie Granger

CONTACT

206-215-2466 tracie.granger@swedish.org

Sponsors

Lead Sponsor

Swedish Medical Center

Age

19 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adult patients (\>18 yo) with a pathological diagnosis of metastatic brain cancer
•Participants must have \>4 tumors felt to require stereotactic radiosurgery
•Karnofsky scale of \> 70 at the time of initial treatment
•Age \< 80

Exclusion Criteria

•Karnofsky scale \<70
•Age \> 80
•Inability to undergo MR imaging studies

Related studies

Targeted Pediatric High-Grade Glioma Therapy

NCT05839379 · High Grade Glioma, Diffuse Intrinsic Pontine Glioma, and more

RECRUITINGPhase 1

F-Tryptophan PET/CT in Human Cancers

NCT05556473 · Intracranial Glioma, Metastatic Brain Tumor, and more

Assessment of Eloquent Function in Brain Tumor Patients

NCT01535430 · Primary Brain Tumor, Metastatic Brain Tumor

Active Not RecruitingNA

A Study of How Proton Beam Radiotherapy (PBRT) Affects Brain Function and Quality of Life in Children and Young Adults Undergoing Treatment for a Brain Tumor

NCT05288439 · Brain Tumor, Metastatic Brain Tumor

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

NCT02392078 · Metastatic Brain Tumor, Primary Brain Tumor, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 25, 2013Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment100

Start dateJan 2013

Last updatedJul 25, 2013

Condition

Metastatic Brain Tumor

Locations shown

Swedish Medical Center

Seattle, Washington

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 25, 2013Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions